Citation Impact
Citing Papers
The IASP classification of chronic pain for ICD-11: chronic primary pain
2018 Standout
The current economic burden of cirrhosis.
2011
Social prescribing: less rhetoric and more reality. A systematic review of the evidence
2017 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
Nurse staffing and patient outcomes: Strengths and limitations of the evidence to inform policy and practice. A review and discussion paper based on evidence reviewed for the National Institute for Health and Care Excellence Safe Staffing guideline development
2016
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
2019 Standout
Management of Sickle Cell Disease
2014
Pelvic pain: a pathway for care developed for both men and women by the British Pain Society
2014
2013 Alzheimer's disease facts and figures
2013 Standout
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Sickle cell disease
2017
Management of Patients with Sickle Cell Disease Using Transfusion Therapy
2016
Preparing the prescription: a review of the aim and measurement of social referral programmes
2017
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Update on optimal use of omalizumab in management of asthma
2011
IgE and mast cells in allergic disease
2012 Standout
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
2011
When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts
2017 Standout
Burnout in nursing: a theoretical review
2020 Standout
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
2011
Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood
2012
Understanding the effectiveness and mechanisms of a social prescribing service: a mixed method analysis
2018 Standout
Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches?
2011
Asthma
2017 Standout
Preparing Medical Imaging Data for Machine Learning
2020 Standout
Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
2017
Parkinson's disease
2015 Standout
Intra‐articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders
2008
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
2014 Standout
Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research
2015
Chronic kidney disease: global dimension and perspectives
2013 Standout
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
2021 Standout
Alzheimer's disease
2016 Standout
Sickle-cell disease
2010 Standout
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Rheumatoid arthritis
2010 Standout
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
2008
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain
2018
Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review
2017 Standout
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
2015 StandoutNobel
Key challenges for delivering clinical impact with artificial intelligence
2019 Standout
When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
2013
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
2016 StandoutNobel
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Sponsorship-Related Outcome Selection Bias in Published Economic Studies of Triptans
2011
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
The association between nurse staffing and omissions in nursing care: A systematic review
2018 Standout
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents
2009
Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs
2019
Link workers’ perspectives on factors enabling and preventing client engagement with social prescribing
2019 Standout
Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease
2016
Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer’s Disease
2015
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Diabetic Kidney Disease
2017 Standout
Transfusion therapy for sickle cell disease: a balancing act
2013
Plasma tau in Alzheimer disease
2016 StandoutNobel
Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis
2015
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Surgery for weight loss in adults
2014 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Plans to accelerate innovation in health systems are less than IDEAL
2015
What impact does nursing care left undone have on patient outcomes? Review of the literature
2017 Standout
Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care – the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Suicidality) programme
2018
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Red blood cell exchange in patients with sickle cell disease—indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB
2018
Industry sponsorship and research outcome
2017 Standout
What approaches to social prescribing work, for whom, and in what circumstances? A realist review
2019 Standout
Vascular access for red blood cell exchange
2018
Health Care–Associated Infection After Red Blood Cell Transfusion
2014
Works of Eldon Spackman being referenced
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
2012
The clinical and cost-effectiveness of the BRinging Information and Guided Help Together (BRIGHT) intervention for the self-management support of people with stage 3 chronic kidney disease in primary care: study protocol for a randomized controlled trial
2013
The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective
2010
Effect of Information and Telephone-Guided Access to Community Support for People with Chronic Kidney Disease: Randomised Controlled Trial
2014
Does the Funding Source Influence the Results in Economic Evaluations?
2010
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial
2013
A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
2008
Cost-Effectiveness Uncertainty Analysis Methods
2014
Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk Profiles
2006
Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease
2011
Cost-effectiveness of biologic agents for treatment of autoimmune disorders: structured review of the literature.
2006
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
2015